Amilpar - Press Release - Commercial Papers

Saturday, December 12, 2009 Press Release
Email Print This Page Comment
Font : A-A+

RIO DE JANEIRO, Dec. 11 Amilpar (Bovespa: AMIL3;Bloomberg: AMIL3 BZ and APAR < GO >; Reuters: AMIL3.SA), the largest managedcare organization in Brazil, in accordance with CVM (Brazilian Securities andExchange Commission) Instruction 358/02, informs that the 1st Issuance ofCommercial Papers for public distribution with restricted selling efforts(according to CVM Instruction 476/09), was approved in a Board Meeting heldtoday, with the objective of increasing the Company's cash position after theacquisition of Medial Saude S.A. control, under the following terms andconditions:Total Amount: R$ 300 million Term: 360 days, with the option of anticipating redemption Remuneration: 110% of CDI (average interbank deposit rate in Brazil) Coordinator: Banco Bradesco BBI S.A. To access the Press Release visit our website at www.amilpar.com.br/ir IR Contact Erwin Kleuser Investor Relations Officer Phone: +55 (21) 3805-1155 invest@amil.com.br www.amilpar.com.br/ir

SOURCE Amilpar


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook